Intent of Surgery for IPMN
Start Date
9/15/2025
Completion Date
12/1/2025
Summary
This multicenter retrospective observational cohort study seeks to: 1. Classify surgical intent in patients with resected Intraductal Papillary Mucinous Neoplasms (IPMN) and quantify the proportion of IPMN-associated cancers diagnosed as overt pancreatic cancer with incidental IPMN association on pathology. 2. Compare clinicopathologic features and outcomes between surveillance-detected and incidentally detected IPMN-derived pancreatic cancers. 3. Revise and redefine risk features limited to patients undergoing surgery for IPMN-related indications, identifying optimal predictors of malignant IPMN (high-grade dysplasia or invasive cancer).
Eligibility Criteria
Age Range: 18 years to No maximum
Conditions
Locations
Mayo Clinic
Phoenix, Arizona 85054
United States
Johns Hopkins University
Baltimore, Maryland 21287
United States
Massachusetts General Hospital
Boston, Massachusetts 02114
United States
Mayo Clinic
Rochester, Minnesota 55905
United States
NYU Langone Health
New York, New York 10016
United States
Memorial Sloan Kettering
New York, New York 10022
United States
Duke University
Durham, North Carolina 27710
United States
MD Anderson Cancer Center
Houston, Texas 77030
United States
Nanjing University
Nanjing, 210093
China
Heidelberg University
Heidelberg, 69117
Germany
San Raffaele Hospital
Milan, 20132
Italy
Padua University
Padua, 1222
Italy
University of Amsterdam
Amsterdam, 1105
Netherlands
University of Utrecht
Utrecht, 3584
Netherlands